Rolando Cimaz1,2, Eleonora Fanti3, Angela Mauro4, Fabio Voller3, Franca Rusconi5. 1. Rheumatology Unit, Anna Meyer Children's Hospital, Viale Pieraccini 24, 50139, Florence, Italy. r.cimaz@meyer.it. 2. Neurofarba Department, University of Florence, Florence, Italy. r.cimaz@meyer.it. 3. Epidemiology Unit, Regional Health Agency of Tuscany, Florence, Italy. 4. Department of Pediatrics, San Giacomo Hospital, Novi Ligure, Italy. 5. Epidemiology Unit, Anna Meyer Children's University Hospital, Florence, Italy.
Abstract
Kawasaki disease is a systemic vasculitis with an acute and self-limited course. The incidence of the disease differs widely among ethnic groups and is higher in the Asian populations. In Italy, no recent data are available. We studied the epidemiology of Kawasaki disease in the years 2008-2013 in children 0-14 years old in Italy using hospital ICD-9 discharge codes with a thorough data cleaning for duplicates in order to select the first hospital admission for the disease. The disease peaked in the first 2 years of life, with 85.5% of cases under 5 years. Male/female ratio was 1.4:1. The incidence rate was 5.7 per 100,000 children 0-14 years old and 14.7 for children younger than 5 years. The incidence rose slightly during the study period and had a seasonal distribution, with higher incidence in spring. A coronary artery aneurysm was recorded in 2.2% of the patients younger than 5 years of age. CONCLUSION: This is the first epidemiologic study on Kawasaki disease incidence in the country of Italy. Figures are in line but slightly higher than those reported for other European countries. What is known: • Kawasaki disease is more common in Asian populations. • European incidence data are scarce. What is new: • Epidemiological data in Italy show similar incidence, albeit slightly higher, than in other European countries. • Incidence data slightly rose in the recent past.
Kawasaki disease is a systemic vasculitis with an acute and self-limited course. The incidence of the disease differs widely among ethnic groups and is higher in the Asian populations. In Italy, no recent data are available. We studied the epidemiology of Kawasaki disease in the years 2008-2013 in children 0-14 years old in Italy using hospital ICD-9 discharge codes with a thorough data cleaning for duplicates in order to select the first hospital admission for the disease. The disease peaked in the first 2 years of life, with 85.5% of cases under 5 years. Male/female ratio was 1.4:1. The incidence rate was 5.7 per 100,000 children 0-14 years old and 14.7 for children younger than 5 years. The incidence rose slightly during the study period and had a seasonal distribution, with higher incidence in spring. A coronary artery aneurysm was recorded in 2.2% of the patients younger than 5 years of age. CONCLUSION: This is the first epidemiologic study on Kawasaki disease incidence in the country of Italy. Figures are in line but slightly higher than those reported for other European countries. What is known: • Kawasaki disease is more common in Asian populations. • European incidence data are scarce. What is new: • Epidemiological data in Italy show similar incidence, albeit slightly higher, than in other European countries. • Incidence data slightly rose in the recent past.
Authors: Yong Won Park; Ji Whan Han; Young Mi Hong; Jae Sook Ma; Sung Ho Cha; Tae Chan Kwon; Sang Bum Lee; Chul Ho Kim; Joon Sung Lee; Chang Hwi Kim Journal: Pediatr Int Date: 2011-02 Impact factor: 1.524
Authors: Eeva Salo; Elizabeth P Griffiths; Teresa Farstad; Bodil Schiller; Yosikazu Nakamura; Mayumi Yashiro; Ritei Uehara; Brookie M Best; Jane C Burns Journal: Pediatr Int Date: 2012-10-08 Impact factor: 1.524
Authors: Robert C Holman; Krista Y Christensen; Ermias D Belay; Claudia A Steiner; Paul V Effler; Jill Miyamura; Susan Forbes; Lawrence B Schonberger; Marian Melish Journal: Hawaii Med J Date: 2010-08
Authors: Carline E Tacke; Willemijn B Breunis; Rob Rodrigues Pereira; Johannes M Breur; Irene M Kuipers; Taco W Kuijpers Journal: Pediatr Infect Dis J Date: 2014-08 Impact factor: 2.129
Authors: F Falcini; R Cimaz; G B Calabri; P Picco; G Martini; M G Marazzi; G Simonini; F Zulian Journal: Clin Exp Rheumatol Date: 2002 May-Jun Impact factor: 4.473
Authors: Leyre Riancho-Zarrabeitia; Domingo F Rasilla; Dominic Royé; Pablo Fdez-Arroyabe; Ana Santurtún Journal: Rheumatol Int Date: 2018-05-30 Impact factor: 2.631
Authors: Corinne Willame; Caitlin Dodd; Lieke van der Aa; Gino Picelli; Hanne-Dorthe Emborg; Johnny Kahlert; Rosa Gini; Consuelo Huerta; Elisa Martín-Merino; Chris McGee; Simon de Lusignan; Giuseppe Roberto; Marco Villa; Daniel Weibel; Lina Titievsky; Miriam C J M Sturkenboom Journal: Drug Saf Date: 2021-01-19 Impact factor: 5.606
Authors: Chaw-Liang Chang; Chih-Shung Wong; Yi-Chen Yang; Nan-Chang Chiu Journal: Int J Environ Res Public Health Date: 2018-04-25 Impact factor: 3.390